1 / 6

Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 201

RnRMarketResearch adds ‘Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015’ to its store. This report provides comprehensive information on the current therapeutic developmental pipeline of Ligand Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages.

rudrak123
Download Presentation

Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 201

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 By RnRMarketResearch Publisher Name : Global Markets Direct Date: 22-Apr-2015 No. of pages: 57 Single User License: US $1500 Browse more reports on Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 Global Markets Direct’s, ‘Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015′, provides an overview of the Ligand Pharmaceuticals, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ligand Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 Scope: • The report provides brief overview of Ligand Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries • The report reviews current pipeline of Ligand Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones • Special feature on out-licensed and partnered product portfolio ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 Reasons to Buy: • Evaluate Ligand Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline • Assess the growth potential of Ligand Pharmaceuticals, Inc. in its therapy areas of focus • Identify new drug targets and therapeutic classes in the Ligand Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps • Develop strategic initiatives by understanding the focus areas of Ligand Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related